Oscar Health (OSCR) Stock Price, News & Analysis

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OSCR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSCR, but not buy additional shares or sell existing shares.
View OSCR analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 12-month price objectives for Oscar Health's shares. Their OSCR share price targets range from $6.00 to $9.00. On average, they expect the company's stock price to reach $7.70 in the next year. This suggests that the stock has a possible downside of 4.5%.
View analysts price targets for OSCR or view top-rated stocks among Wall Street analysts.

Oscar Health's stock was trading at $2.46 at the beginning of 2023. Since then, OSCR stock has increased by 227.6% and is now trading at $8.06.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our OSCR earnings forecast.

Oscar Health, Inc. (NYSE:OSCR) issued its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.18. The business had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.42 billion. Oscar Health had a negative net margin of 6.39% and a negative trailing twelve-month return on equity of 37.51%. The firm's quarterly revenue was up 47.2% on a year-over-year basis. During the same period in the previous year, the company posted ($0.91) earnings per share.

ETFs with the largest weight of Oscar Health (NYSE:OSCR) stock in their portfolio include Invesco Dorsey Wright Healthcare Momentum ETF (PTH), SoFi Be Your Own Boss ETF (BYOB) and SoFi Be Your Own Boss ETF (GIGE).iShares U.S. Insurance ETF (IAK).

207 employees have rated Oscar Health Chief Executive Officer Mario T. Schlosser on Glassdoor.com. Mario T. Schlosser has an approval rating of 95% among the company's employees. This puts Mario T. Schlosser in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 70.0% of employees surveyed would recommend working at Oscar Health to a friend.

(OSCR) raised $1 billion in an initial public offering (IPO) on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at a price of $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse acted as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

Oscar Health's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include General Catalyst Group Management LLC (3.01%), Ancient Art L.P. (1.26%), UBS Group AG (0.67%), Northern Trust Corp (0.66%), Charles Schwab Investment Management Inc. (0.51%) and Assenagon Asset Management S.A. (0.48%). Insiders that own company stock include Alessandrea C Quane, Alphabet Inc, Ari Fischel, Dennis Weaver, Joel Klein, Joshua Kushner, Mario Schlosser, Meghan V Joyce, Ranmali Bopitiya, Richard Scott Blackley, Sid Sankaran, Thrive Partners Vii Growth Gp, and Victoria Baltrus.
View institutional ownership trends.

Shares of OSCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.